Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Activities:    
Net Income (loss) $ (19,019) $ 4,239
Adjustments to reconcile net profit (loss) to cash used in operating activities    
Depreciation, amortization, and non-cash lease interest 2,430 1,163
Provision for doubtful accounts (523) (43)
Reserve for excess and obsolete inventory 150 109
Change in fair value of warrant liabilities (189) (693)
Change in fair value of contingent earnout liability (808) (24,896)
Amortization (accretion) of (discounts) premiums on available-for-sale securities (670) 0
Stock-based compensation expense 4,356 5,422
Changes in operating assets and liabilities, net of effects of businesses acquired    
Accounts receivable 3,708 4,014
Inventory (2,998) (2,533)
Prepaid expenses 511 285
Other current assets (28) (1,376)
Other assets 85 (236)
Accounts payable and accrued expenses (2,117) (4,152)
Other current liabilities 0 (82)
Deferred revenue 788 145
Other non-current lease liabilities (1,218) (613)
Net cash used in operating activities (15,542) (19,247)
Investing Activities:    
Purchases of property and equipment (1,646) (798)
Purchases of available-for-sale securities (18,950) 0
Proceeds from sales and maturities of marketable securities 2,500 0
Net cash used in investing activities (18,096) (798)
Financing Activities:    
Proceeds from the exercise of common stock options 180 580
Taxes paid related to net share settlement of equity awards (118) 0
Net cash provided by (used in) financing activities 62 580
Effect of exchange rate changes on cash 8  
Net change in cash, cash equivalents, and restricted cash (33,568) (19,465)
Cash and cash equivalents and restricted cash    
Beginning of year 124,242 288,603
End of period 90,674 269,138
Supplemental disclosures of cash flow information    
Cash and cash equivalents 90,674 269,138
Restricted cash 1,430 0
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 92,104 269,138
Non-cash financing and investing activities    
Purchase of property and equipment in accounts payable and accrued expenses $ 899 $ 83